Struggling Valeant Raises $3.25B In Bonds To Revamp Debt
Drug giant Valeant Pharmaceuticals International Inc. on Friday said that it has priced an upsized debt offering totaling $3.25 billion in high-yield bonds, and will use proceeds to restructure its heavy...To view the full article, register now.
Already a subscriber? Click here to view full article